#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
A giant cell tumor is a benign solitary tumor that usually grows in the ends of long bones, and contains unusually large cells that are called giant cells.
A giant cell tumor is considered benign, yet giant cell tumors can spread to the lungs. Don't worry too much, though-this rarely happens.
When it does occur, the prognosis for your child is still good; occasionally the tumor regresses without intervention.
Collaboration and innovation
Working together with clinicians and researchers at the Dana Farber Cancer Institute and Harvard Medical School, the Head, Neck and Skull Base Surgery Program is dedicated to advancing the understanding, diagnosis, treatment, cure and prevention of giant cell tumors and related conditions.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”